Beijing Winsunny Pharmaceutical CO.LTD (601089.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100005QF9

Price
15.40 CNY
Market cap
7.39 bn CNY
P/E (2025)
15.75
P/S (2025)
2.11
Dividend yield
3.25 %
Net margin
13.39 %
Return on equity (ROE)
12.42 %
Return on assets (ROA)
9.53 %

Beijing Winsunny Pharmaceutical CO.LTD financials

Fiscal year20242025
Revenue3.45 bn CNY3.50 bn CNY
Gross profit2.31 bn CNY2.30 bn CNY
Operating income507.50 m CNY523.66 m CNY
EBIT543.62 m CNY524.92 m CNY
Net income488.67 m CNY469.36 m CNY
Diluted EPS – continuing operations1.02 CNY0.98 CNY

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Beijing Winsunny Pharmaceutical CO.LTD

Beijing Foyou Pharma CO.,LTD engages in the research and development, production, and sale of pharmaceutical formulation and medical devices China. The company offers chemical drugs; traditional Chinese medicine; raw materials; and medical devices, such as negative pressure drainage device, digital urine collection bags, dynamic urine output monitor, disposable pressure sensor, urodynamic monitoring device, nasal air filter, medical micro-mesh nebulizer, disposable atomizer, disposable oxygen mask, and disposable oxygen tubing. It sells its products through medical institutions and retail outlets. The company's products cover cardiovascular system, chronic kidney disease, dermatology, digestive system, diabetes, neuropsychiatric system, and gynecology areas. Beijing Foyou Pharma CO.,LTD was incorporated in 1999 and is headquartered in Beijing, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.